Antiretroviral preexposure prophylaxis for HIV prevention.

Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med (2013) 0.96

Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med (2013) 0.93

Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med (2013) 0.77

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03

Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis (2008) 5.94

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56

A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med (2013) 4.14

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 3.78

Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis (2010) 2.86

Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One (2012) 2.33

Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis (2003) 2.22

Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev (2010) 2.09

Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J (2009) 1.91

Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation (2005) 1.80

Determinants of male involvement in maternal and child health services in sub-Saharan Africa: a review. Reprod Health (2012) 1.75

Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial. J Acquir Immune Defic Syndr (2008) 1.70

Acceptability of HIV self-testing: a systematic literature review. BMC Public Health (2013) 1.70

Mycobacterium-associated immune reconstitution disease: macrophages running wild? Lancet Infect Dis (2006) 1.68

Knowledge, health seeking behavior and perceived stigma towards tuberculosis among tuberculosis suspects in a rural community in southwest Ethiopia. PLoS One (2010) 1.63

Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes (2009) 1.62

Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 1.58

ART in low-resource settings: how to do more with less. Lancet (2010) 1.52

Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr (2010) 1.49

Etiology and outcome of fever after a stay in the tropics. Arch Intern Med (2006) 1.47

Predictors of HIV testing among patients with tuberculosis in North West Ethiopia: a case-control study. PLoS One (2010) 1.45

Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005. AIDS (2005) 1.45

Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health (2009) 1.45

Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr (2003) 1.44

Common mental disorders in TB/HIV co-infected patients in Ethiopia. BMC Infect Dis (2010) 1.41

An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr (2009) 1.40

[Biological and pathological data in a case of yellow fever imported from the Gambia]. Ann Pathol (2005) 1.39

A telemedicine service for HIV/AIDS physicians working in developing countries. J Telemed Telecare (2010) 1.38

What do the xenophobic attacks reveal about the health of South African society? S Afr Med J (2008) 1.37

The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol (2013) 1.33

Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33

Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda. BMC Infect Dis (2013) 1.33

Sexual risk reduction needs of adolescents living with HIV in a clinical care setting. AIDS Care (2008) 1.30

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis (2011) 1.29

Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Trop Med Int Health (2014) 1.26

Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am J Trop Med Hyg (2006) 1.26

Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med (2012) 1.25

Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc (2009) 1.25

The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci (2008) 1.25

Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable. Trop Med Int Health (2009) 1.23

Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis (2012) 1.18

CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr (2006) 1.17

An autopsy study describing causes of death and comparing clinico-pathological findings among hospitalized patients in Kampala, Uganda. PLoS One (2012) 1.17

HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. J Infect Dis (2006) 1.17

Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis (2008) 1.16

Short communication: a cluster of Marburg virus disease involving an infant. Trop Med Int Health (2002) 1.14

Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect (2005) 1.13

Electronic medical records and same day patient tracing improves clinic efficiency and adherence to appointments in a community based HIV/AIDS care program, in Uganda. AIDS Behav (2012) 1.12

Delays in diagnosis and treatment of pulmonary tuberculosis in Wakiso and Mukono districts, Uganda. BMC Public Health (2014) 1.12

Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions. Medicine (Baltimore) (2007) 1.11

"It's better not to know": perceived barriers to HIV voluntary counseling and testing among sub-Saharan African migrants in Belgium. AIDS Educ Prev (2009) 1.11

Risk Factors of Active Tuberculosis in People Living with HIV/AIDS in Southwest Ethiopia: A Case Control Study. Ethiop J Health Sci (2011) 1.10

Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes (2012) 1.10

Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013. MMWR Morb Mortal Wkly Rep (2014) 1.10

Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev Immunol (2010) 1.09

Do patents prevent access to drugs for HIV in developing countries? JAMA (2002) 1.09

Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options. J Infect Dis (2011) 1.08

The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance. Malar J (2008) 1.08

Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. J Microbiol Methods (2010) 1.07

Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity. J Int Assoc Physicians AIDS Care (Chic) (2008) 1.07

Prejudice and misconceptions about tuberculosis and HIV in rural and urban communities in Ethiopia: a challenge for the TB/HIV control program. BMC Public Health (2010) 1.05

Change in quality of life: a follow up study among patients with HIV infection with and without TB in Ethiopia. BMC Public Health (2013) 1.04

Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. J Bone Miner Res (2013) 1.03

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children. AIDS Res Hum Retroviruses (2013) 1.03

Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo. PLoS One (2012) 1.02

The added value of a CD4 count to identify patients eligible for highly active antiretroviral therapy among HIV-positive adults in Cambodia. J Acquir Immune Defic Syndr (2006) 1.00

The International Index of Erectile Function: development of an adapted tool for use in HIV-positive men who have sex with men. J Sex Med (2009) 1.00

HIV prevalence by race co-varies closely with concurrency and number of sex partners in South Africa. PLoS One (2013) 1.00

Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda. Afr Health Sci (2008) 1.00

Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med (2006) 0.99

Impact of HIV-1 infection on the hematological recovery after clinical malaria. J Acquir Immune Defic Syndr (2009) 0.99

Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther (2010) 0.99

Strong association between point-concurrency and national peak HIV prevalence. Int J Infect Dis (2012) 0.98

Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia. BMC Infect Dis (2012) 0.98

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood (2005) 0.98

Strategies for optimizing clinic efficiency in a community-based antiretroviral treatment programme in Uganda. AIDS Behav (2013) 0.97

Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1. AIDS (2002) 0.97

Autopsy acceptance rate and reasons for decline in Mulago Hospital, Kampala, Uganda. Trop Med Int Health (2011) 0.96

Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa. S Afr Med J (2012) 0.95

When to switch for antiretroviral treatment failure in resource-limited settings? AIDS (2007) 0.95

Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr (2011) 0.95

Needle autopsy to establish the cause of death in HIV-infected hospitalized adults in Uganda: a comparison to complete autopsy. J Acquir Immune Defic Syndr (2014) 0.94

Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility. BMC Infect Dis (2008) 0.94

Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome? AIDS (2008) 0.93

Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda. Afr Health Sci (2008) 0.93

Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program. J Acquir Immune Defic Syndr (2012) 0.93

Utilization of HIV and tuberculosis services by health care workers in Uganda: implications for occupational health policies and implementation. PLoS One (2012) 0.92

Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection. AIDS Res Hum Retroviruses (2007) 0.92

Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev (2009) 0.92

Buruli ulcer lesions in HIV-positive patient. Emerg Infect Dis (2010) 0.91

Remote consultations and HIV/AIDS continuing education in low-resource settings. Int J Med Inform (2006) 0.91

The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome. Immunobiology (2013) 0.90

Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS (2015) 0.90

What is the optimal first line antiretroviral therapy in resource-limited settings? PLoS Med (2012) 0.90

Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases. J Med Virol (2003) 0.90

Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda. ISRN AIDS (2012) 0.89

LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients. PLoS One (2013) 0.89